Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer

doi:10.3748/wjg.v20.i17.5098

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 17

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5752)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

392

WORD

227

HTML

3137

Tables (1-4)

238

Sum=3994

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

850

Download

897

Sum=1747

May 7, 2014 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. May 7, 2014; 20(17): 5098-5103
Published online May 7, 2014. doi: 10.3748/wjg.v20.i17.5098

Table 3 Response rate of 83 evaluable esophageal cancer patients n (%)

Group	n	CR	PR	MR	NC
Drug group	32	10 (31.25)	13 (40.63)	7 (21.87)	2 (6.25)
Non-drug group	51	26 (50.98)	14 (27.45)	7(13.73)	4 (7.84)

CR: Complete response; MR: Minor response; PR: Partial response; NC: No change.

Citation: Yu JP, Sun SP, Sun ZQ, Ni XC, Wang J, Li Y, Hu LJ, Li DQ. Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer. World J Gastroenterol 2014; 20(17): 5098-5103
URL: https://www.wjgnet.com/1007-9327/full/v20/i17/5098.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i17.5098